Diaminothiazoles Modify Tau Phosphorylation and Improve the Tauopathy in Mouse Models

Simple item page
dc.contributor.authorZhang, Xuemei
dc.contributor.authorHernandez, Israel
dc.contributor.authorRei, Damien
dc.contributor.authorMair, Waltraud
dc.contributor.authorLaha, Joydev K.
dc.contributor.authorCornwell, Madison E.
dc.contributor.authorCuny, Gregory D.
dc.contributor.authorTsai, Li-Huei
dc.contributor.authorSteen, Judith A. J.
dc.contributor.authorKosik, Kenneth S.
dc.date.accessioned2020-03-10T17:30:56Z
dc.date.available2020-03-10T17:30:56Z
dc.date.issued2013-07
dc.description.abstractAlthough Tau accumulation is a feature of several neurodegenerative conditions, treatment options for these conditions are nonexistent. Targeting Tau kinases represents a potential therapeutic approach. Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3?. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3? in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3×Tg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay. Given the contribution of both CDK5/p25 and GSK3? to Tau phosphorylation, effective treatment of tauopathies may require dual kinase targeting.
dc.identifier.citationCopyright 2013 Journal of Biological Chemistry. Recommended citation: Zhang, Xuemei, Israel Hernandez, Damien Rei, Waltraud Mair, Joydev K. Laha, Madison E. Cornwell, Gregory D. Cuny, Li-Huei Tsai, Judith AJ Steen, and Kenneth S. Kosik. "Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models." Journal of Biological Chemistry 288, no. 30 (2013): 22042-22056.doi: 10.1074/jbc.M112.436402. URL: http://www.jbc.org/content/288/30/22042. Reproduced in accordance with the original publisher's licensing terms and with permission from the authors.
dc.identifier.urihttps://hdl.handle.net/10657/5934
dc.language.isoen_US
dc.publisherJournal of BIological Chemistry
dc.subjectAlzheimer Disease
dc.subjectCDK(Cyclin-dependent kinase)
dc.subjectGlycogen Synthase Kinase 3
dc.subjectNeurodegenerative diseases
dc.subjectProtein Phosphorylation
dc.subjectKinase Inhibitor
dc.subjectTauopathy
dc.titleDiaminothiazoles Modify Tau Phosphorylation and Improve the Tauopathy in Mouse Models
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cuny_2013_DiaminothiazolesModify.pdf
Size:
3.39 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.69 KB
Format:
Plain Text
Description:
Download

Collections

UH Faculty, Staff, and Student Works